What is Immunome's revenue?

Immunome (IMNM) reported revenue of $0 in Q1 2026.

How has Immunome's revenue changed year-over-year?

Immunome's revenue decreased by 100.0% year-over-year, from $2.93M to $0.

What is the long-term trend for Immunome's revenue?

Over 2 years (2023 to 2025), Immunome's revenue has grown at a -29.6% compound annual growth rate (CAGR), from $14.02M to $6.94M.

Immunome IMNM Revenue

Revenue at other companies

DJT

Trump Media & Technology GroupDJT

$871.2K+6.1%

ADMA BiologicsADMA

$114.49M-0.3%

Cal-Maine FoodsCALM

$666.95M-53.0%

Ollie's Bargain Outlet Holdings, Inc.OLLI

$658.93M+14.2%

PhotronicsPLAB

$209.94M-0.5%

First BanCorpFBP

$258.64M+4.2%

Other financials

Income statement

See full

Revenue--100%

Operating income-$59.3M-32.9%

Net income-$53.8M-29.3%

EPS (diluted)-$0.48+7.7%

Balance sheet

See full

Cash & equivalents$582.7M+126%

Total debt$3.7M-22.6%

Total equity$588.7M+91.7%

Total assets$619.8M+80.9%

Cash flow

See full

Operating cash flow-$58.6M-10.5%

CapEx$3.0M-18.1%

Free cash flow-$61.6M-8.7%

Valuation

See full

Market cap$2.24B+323%

Enterprise value$1.66B+470%

P/S557.1×+509×

Profitability

See full

Operating margin-5,947.9%-12,002pp

Net margin-5,593.8%-11,284pp

FCF margin-5,118.9%-8,601pp

Returns & leverage

See full

Return on equity-50.1%-10.8pp

Debt / equity0×0.0×

Current ratio21.7×+11.2×

Where this comes from

Reported directly by Immunome in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Immunome’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Immunome's revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Immunome's revenue?: Immunome (IMNM) reported revenue of $0 in Q1 2026.
How has Immunome's revenue changed year-over-year?: Immunome's revenue decreased by 100.0% year-over-year, from $2.93M to $0.
What is the long-term trend for Immunome's revenue?: Over 2 years (2023 to 2025), Immunome's revenue has grown at a -29.6% compound annual growth rate (CAGR), from $14.02M to $6.94M.